Obi Greenman

CEO

Equibles does not estimate personal net worth.

Get an email with a short summary when Cerus Corp publishes a filing, an earnings call transcript or a press release.

About Obi Greenman

Obi Greenman is recorded as CEO at Cerus Corp (CERS). Obi Greenman has spoken on 21 earnings calls across 1 company, most recently for Cerus Corp on April 30, 2026. Cerus Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Cerus Corp includes Vivek Jayaraman (CEO, COO and Board Member), William M. Greenman (CEO, Chairman and Board Member), William "Obi" Greenman (Chairman) and 7 others.

Obi Greenman on recent calls

“I want to thank all of you for joining us today for what will be my final earnings call as Sirius' President and CEO.”

CEO, Cerus Corp Q1 FY2026 Earnings Call · April 30, 2026

“At Cerus, we are dedicated to safeguarding the world's blood supply. Every day, patients around the world rely on safe blood from patients undergoing cancer therapy to sickle cell and thalassemia patients to surgical trauma.”

CEO, Earnings conference call (announced in 8-K) · March 2, 2026

“I'm pleased to report that Cirrus continues to build on its strong momentum, delivering another quarter of solid commercial, operational, and financial execution, as well as continued progress across our development priorities that we spelled out at the beginning of the As we close in on the end of 2025, it's clear…”

CEO, Cerus Corp Q3 FY2025 Earnings Call · November 6, 2025

“I am very happy to report to you all today the solid position Cerus is in as we continue to grow our global business upon the strong foundation that we have built in establishing a new standard of care in transfusion medicine.”

CEO, Cerus Corp Q1 FY2025 Earnings Call · May 1, 2025

“I’d like to open the call by spending a few minutes reflecting on our strong performance in 2024 as well as our expectations for full year 2025 as we continue to establish our INTERCEPT blood system as a standard of care in transfusion medicine.”

CEO, Cerus Corp Q4 FY2024 Earnings Call · February 20, 2025